UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
11.47
-0.17 (-1.46%)
At close: May 01, 2025, 3:59 PM
11.30
-1.48%
Pre-market: May 02, 2025, 06:22 AM EDT
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending December 31, 2024, UroGen Pharma generated $24.57M in revenue.
Revenue (ttm)
$90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
$384.67K
Employees
235
Market Cap
528.7M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|